Scitara
Private Company
Total funding raised: $51.5M
Overview
Scitara operates in the digital health and AI/ML sectors, offering a specialized iPaaS solution for modernizing laboratory operations. The company's DLX platform enables labs to connect disparate instruments and informatics systems, automate manual data workflows with low/no-code tools, and monitor all data movements for compliance and integrity. Targeting R&D, bioprocessing, and quality control labs in pharmaceutical and other process-based industries, Scitara aims to drive efficiency, reduce errors, and unlock data for advanced analytics and AI initiatives.
Technology Platform
Scitara DLX, a cloud-based, laboratory-specific Integration Platform as a Service (iPaaS). It provides pre-built connectors for lab instruments and systems, a no/low-code workflow orchestration editor, and a monitoring console for data integrity and compliance.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Scitara competes with large laboratory informatics vendors (e.g., Thermo Fisher, LabVantage) that offer proprietary, but often closed, integration within their own ecosystems, and with general-purpose enterprise iPaaS players (e.g., MuleSoft, Boomi) that lack deep domain expertise in laboratory workflows and compliance requirements. Its differentiation lies in its lab-specific focus, vendor-agnostic connectivity, and composable architecture.